Literature DB >> 18704911

Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response.

Ulrika Westerlind1, Alexandra Hobel, Nikola Gaidzik, Edgar Schmitt, Horst Kunz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18704911     DOI： 10.1002/anie.200802102

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  19 in total

1.  Protective Epitope Discovery and Design of MUC1-based Vaccine for Effective Tumor Protections in Immunotolerant Mice.

Authors:  Xuanjun Wu; Zhaojun Yin; Craig McKay; Christian Pett; Jin Yu; Manuel Schorlemer; Trevor Gohl; Suttipun Sungsuwan; Sherif Ramadan; Claire Baniel; Anthony Allmon; Rupali Das; Ulrika Westerlind; M G Finn; Xuefei Huang
Journal:  J Am Chem Soc       Date:  2018-11-19       Impact factor: 15.419

Review 2.  Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

Authors:  Seema Chugh; Vinayaga S Gnanapragassam; Maneesh Jain; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2015-08-28

Review 3.  Translating tumor antigens into cancer vaccines.

Authors:  Luigi Buonaguro; Annacarmen Petrizzo; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

4.  Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.

Authors:  Raymond P Brinãs; Andreas Sundgren; Padmini Sahoo; Susan Morey; Kate Rittenhouse-Olson; Greg E Wilding; Wei Deng; Joseph J Barchi
Journal:  Bioconjug Chem       Date:  2012-07-31       Impact factor: 4.774

5.  Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.

Authors:  Sampat Ingale; Margreet A Wolfert; Therese Buskas; Geert-Jan Boons
Journal:  Chembiochem       Date:  2009-02-13       Impact factor: 3.164

6.  From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.

Authors:  Jianglong Zhu; Qian Wan; Dongjoo Lee; Guangbin Yang; Maria K Spassova; Ouathek Ouerfelli; Govind Ragupathi; Payal Damani; Philip O Livingston; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

7.  One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.

Authors:  Hamed Malekan; Gabriel Fung; Vireak Thon; Zahra Khedri; Hai Yu; Jingyao Qu; Yanhong Li; Li Ding; Kit S Lam; Xi Chen
Journal:  Bioorg Med Chem       Date:  2013-03-07       Impact factor: 3.641

Review 8.  Recent development in carbohydrate-based cancer vaccines.

Authors:  Zhongwu Guo; Qianli Wang
Journal:  Curr Opin Chem Biol       Date:  2009-09-18       Impact factor: 8.822

9.  Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses.

Authors:  Partha Karmakar; Kyunghee Lee; Sourav Sarkar; Katherine A Wall; Steven J Sucheck
Journal:  Bioconjug Chem       Date:  2015-12-09       Impact factor: 4.774

10.  A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis.

Authors:  Insik Jeon; Dongjoo Lee; Isaac J Krauss; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.